BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 35746659)

  • 1. Gastrointestinal Involvement in SARS-CoV-2 Infection.
    Chen TH; Hsu MT; Lee MY; Chou CK
    Viruses; 2022 May; 14(6):. PubMed ID: 35746659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of SARS-CoV-2 infection for neurogastroenterology.
    Marasco G; Lenti MV; Cremon C; Barbaro MR; Stanghellini V; Di Sabatino A; Barbara G
    Neurogastroenterol Motil; 2021 Mar; 33(3):e14104. PubMed ID: 33591607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
    Suryana KD; Simadibrata M; Renaldi K
    Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease-2019 and the intestinal tract: An overview.
    Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
    World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
    Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
    Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections.
    Cyprian F; Sohail MU; Abdelhafez I; Salman S; Attique Z; Kamareddine L; Al-Asmakh M
    Int J Infect Dis; 2021 Apr; 105():540-550. PubMed ID: 33610778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and Covid-19- possible link and implications.
    Dhar D; Mohanty A
    Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
    Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
    World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory effect on the gastrointestinal system associated with COVID-19.
    Delgado-Gonzalez P; Gonzalez-Villarreal CA; Roacho-Perez JA; Quiroz-Reyes AG; Islas JF; Delgado-Gallegos JL; Arellanos-Soto D; Galan-Huerta KA; Garza-Treviño EN
    World J Gastroenterol; 2021 Jul; 27(26):4160-4171. PubMed ID: 34326616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on the Mutual Impact between SARS-CoV-2 Infection and Gut Microbiota.
    Li S; Zhou Y; Yan D; Wan Y
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
    Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal involvement in children with SARS-COV-2 infection: An overview for the pediatrician.
    Chiappini E; Licari A; Motisi MA; Manti S; Marseglia GL; Galli L; Lionetti P
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):92-95. PubMed ID: 33236437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can SARS-CoV-2 be transmitted via faeces?
    Moura IB; Buckley AM; Wilcox MH
    Curr Opin Gastroenterol; 2022 Jan; 38(1):26-29. PubMed ID: 34628417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.